Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study
<h4>Objective</h4> Pulmonary arteriovenous malformation (PAVM) is a rare pulmonary disease. Although most patients with PAVMs are asymptomatic, cerebral complications associated with PAVMs are often fatal. This study aimed to evaluate the risk factors for cerebral complications in patien...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714939/?tool=EBI |
_version_ | 1811208980917125120 |
---|---|
author | Young-Ok Na Hwa Kyung Park Jae-Kyeong Lee Bo-Gun Kho Tae-Ok Kim Hong-Joon Shin Yong-Soo Kwon Yu-Il Kim Sung-Chul Lim Hyung-Joo Oh Cheol-Kyu Park In-Jae Oh Young-Chul Kim Ha-Young Park |
author_facet | Young-Ok Na Hwa Kyung Park Jae-Kyeong Lee Bo-Gun Kho Tae-Ok Kim Hong-Joon Shin Yong-Soo Kwon Yu-Il Kim Sung-Chul Lim Hyung-Joo Oh Cheol-Kyu Park In-Jae Oh Young-Chul Kim Ha-Young Park |
author_sort | Young-Ok Na |
collection | DOAJ |
description | <h4>Objective</h4> Pulmonary arteriovenous malformation (PAVM) is a rare pulmonary disease. Although most patients with PAVMs are asymptomatic, cerebral complications associated with PAVMs are often fatal. This study aimed to evaluate the risk factors for cerebral complications in patients with PAVMs. <h4>Methods</h4> We retrospectively reviewed the medical charts of patients with PAVMs between 2003 and 2021 at two tertiary referral hospitals and one secondary hospital. <h4>Results</h4> Fifty-five patients diagnosed with PAVMs were enrolled in this study. Most patients were female (89.1%), and the median age was 53 years. Thirty patients (54.5%) had incidentally detected PAVMs without symptoms. Twenty-four patients (43.7%) with PAVMs were treated with embolotherapy or surgery. Thirteen patients (23.6%) had cerebral complications. There was no significant difference in the development of cerebral complications according to treatment; however, older age (≥ 65 years) was associated with the development of new cerebral complications in untreated patients with PAVMs (odds ratio, 17.09; 95% confidence interval, 1.16–250.31; P = 0.038). <h4>Conclusion</h4> Older age (≥ 65 years) was a risk factor for the development of cerebral complications in patients with PAVMs; therefore, treatment should be considered in older patients with PAVMs. |
first_indexed | 2024-04-12T04:31:08Z |
format | Article |
id | doaj.art-55f8e835133846938cf0d57dbea135d2 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-12T04:31:08Z |
publishDate | 2022-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-55f8e835133846938cf0d57dbea135d22022-12-22T03:47:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011712Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort studyYoung-Ok NaHwa Kyung ParkJae-Kyeong LeeBo-Gun KhoTae-Ok KimHong-Joon ShinYong-Soo KwonYu-Il KimSung-Chul LimHyung-Joo OhCheol-Kyu ParkIn-Jae OhYoung-Chul KimHa-Young Park<h4>Objective</h4> Pulmonary arteriovenous malformation (PAVM) is a rare pulmonary disease. Although most patients with PAVMs are asymptomatic, cerebral complications associated with PAVMs are often fatal. This study aimed to evaluate the risk factors for cerebral complications in patients with PAVMs. <h4>Methods</h4> We retrospectively reviewed the medical charts of patients with PAVMs between 2003 and 2021 at two tertiary referral hospitals and one secondary hospital. <h4>Results</h4> Fifty-five patients diagnosed with PAVMs were enrolled in this study. Most patients were female (89.1%), and the median age was 53 years. Thirty patients (54.5%) had incidentally detected PAVMs without symptoms. Twenty-four patients (43.7%) with PAVMs were treated with embolotherapy or surgery. Thirteen patients (23.6%) had cerebral complications. There was no significant difference in the development of cerebral complications according to treatment; however, older age (≥ 65 years) was associated with the development of new cerebral complications in untreated patients with PAVMs (odds ratio, 17.09; 95% confidence interval, 1.16–250.31; P = 0.038). <h4>Conclusion</h4> Older age (≥ 65 years) was a risk factor for the development of cerebral complications in patients with PAVMs; therefore, treatment should be considered in older patients with PAVMs.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714939/?tool=EBI |
spellingShingle | Young-Ok Na Hwa Kyung Park Jae-Kyeong Lee Bo-Gun Kho Tae-Ok Kim Hong-Joon Shin Yong-Soo Kwon Yu-Il Kim Sung-Chul Lim Hyung-Joo Oh Cheol-Kyu Park In-Jae Oh Young-Chul Kim Ha-Young Park Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study PLoS ONE |
title | Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study |
title_full | Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study |
title_fullStr | Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study |
title_full_unstemmed | Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study |
title_short | Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study |
title_sort | risk factors for cerebral complications in patients with pulmonary arteriovenous malformations a multicenter retrospective cohort study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714939/?tool=EBI |
work_keys_str_mv | AT youngokna riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT hwakyungpark riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT jaekyeonglee riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT bogunkho riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT taeokkim riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT hongjoonshin riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT yongsookwon riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT yuilkim riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT sungchullim riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT hyungjoooh riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT cheolkyupark riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT injaeoh riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT youngchulkim riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy AT hayoungpark riskfactorsforcerebralcomplicationsinpatientswithpulmonaryarteriovenousmalformationsamulticenterretrospectivecohortstudy |